Taken from Fina.org (Int swimming regulations - presume it applies to cycling as well) Special note about Declaration of Use The 2011 International Standard for TUEs was only slightly modified. The only section changed was Section 9.0 which refers to the Declaration of Use. In the 2011 Prohibited List, all reference to Declaration of Use has been removed. The Declaration of Use was previously required for three substances: 1. Salbutamol and Salmeterol by inhalation 2. Gluccocorticosteroids by intraarticular, periarticular, peritendionous, epidureal, intradermal and inhalation routes. 3. Platelet-derived preparations (PRP) by all other routes other than intramuscular. PRP by intramuscular injection was removed from the Prohibited List in 2011 and therefore no longer requires a therapeutic use exemption. Note that as per the International Standard for Testing, athletes are still requested to write down all medications or substances taken in the last 7 days on the Doping Control Form, at the time of testing. THERAPEUTIC USE EXEMPTION (TUE) - 2010 Procedures FINA would like to remind competitors, physicians, therapists, coaches, administrators and other members of the FINA Family about the change in status of certain beta-2 agonists which are commonly used to treat asthma, and the re-introduction of pseudoephedrine to the Prohibited List. Effective January 1, 2010 changes to the WADA Prohibited List have resulted in the re-classification of 2 commonly prescribed medications for the care and control of asthma. IT IS IMPORTANT THAT ALL ASTHMATIC COMPETITORS AND THEIR PHYSICIANS ARE MADE AWARE OF THESE CHANGES. Salbutamol and salmeterol are no longer prohibited when administered by inhalation only. Thus it is no longer necessary to request a Therapeutic Use Exemption for their use. They require a “Declaration of Use”, which should be provided to FINA (for international competitors), noted at the time of any testing on the doping control form, or submitted using ADAMS. Salbutamol is still prohibited when administered by any route other than inhalation, e.g. when administered orally (pill form). It is very important to note that if salbutamol is detected during drug testing procedures at a level above 1000 ng/mL, the athlete will have the burden of demonstrating through a controlled study that this urinary level was the result of inhaled, therapeutic, use of this medication. Salbutamol is known as albuterol in the USA. All other beta-2 agonists (e.g. terbutaline and formoterol) are still prohibited when administered by any route, including inhalation, and their use will require a TUE application supported by the appropriate medical information and the results of appropriate pulmonary function tests. In addition, asthmatic athletes selected for doping control must remember to declare the use of all prescribed medications (e.g., asthma medications and glucocorticosteroids) and all non-prescribed medications and supplements taken in the last 10 days.
